Treatment of colorectal cancer

More than 40,000 individuals are affected by colorectal cancer per year, making this one of the commonest cancers in France. When it is detected at an early stage, it can be cured in 9 cases out of 10. Each year Gustave Roussy sees more than 3,000 patients with the condition. The Digestive Diseases Committee is responsible for the management of these patients.

Description

The Gustave Roussy Medical Oncology Department is one of the largest in France with a team of more than 430 personnel. It covers a very wide clinical spectrum consisting of all cancer specialties as well as rare cancers.

Traitement des sarcomes et tumeurs complexes

La chirurgie est la pierre angulaire du traitement curatif des sarcomes, quand celle-ci est possible et que la maladie n'est pas métastatique. Elle peut être associée à de la radiothérapie et/ou à de la chimiothérapie.

Treatment of sarcomas and complex tumours

Gustave Roussy treats patients with soft tissue and bone sarcomas, desmoid tumours, gastrointestinal stromal tumours (GIST) and other complex tumours (chordomas and PEComas).
Sarcomas are tumours which arise in connective tissue (mesenchyme). There are a number of types of mesenchymal tumours whose consequences and severity vary greatly depending on:

Urology Committee

Chairman: Prof. Pierre Blanchard

Oncologists: Pr Laurence Albiges, Dr Alice Bernard Tessier, Dr Solenn Barraud, Dr Mario Di Palma, Dr Bernard Escudier, Dr Alina Fuerea, Dr Ronan Flippot, Pr Yohann Loriot, Dr Natacha Naoun, Dr Anna Patrikidou, Dr Cédric Pobel, Dr Macarena Rey Cardenas

Radiotherapy: Pr Pierre Blanchard, Dr Youssef Ghannam, Dr Mario Terlizzi

En cas de cancer localisé

Il existe plusieurs moyens pour traiter un cancer de la prostate :

La chirurgie

Le traitement chirurgical du cancer de la prostate consiste à enlever la prostate et les vésicules séminales (prostatectomie radicale). Si la chirurgie est nécessaire, elle pourra être pratiquée dans certains cas à Gustave Roussy ou à l'hôpital Bicêtre, partenaire de Gustave Roussy.

Treatment of prostate cancer

Prostate cancer is the commonest cancer in men, with more than 70,000 new cases annually in France. This is usually a slowly developing cancer. It can be completely silent or may be the cause of urinary symptoms such as difficulty in passing urine or frequency of micturition.

Gustave Roussy is a non-profit making private health establishment with a public role.
As a Cancer Centre, its status derives from Directive n° 45-2221 of the 1st October 1945, modified by Directive n° 2005-406 of the 2nd May 2005 and by the "HPST" Law of 21st July 2009 on hospital reform with a bearing on patients, health and local authorities. 

Gustave Roussy is a member of Unicancer, an organisation to which all French Cancer Centres belong.

International Thoracic Cancer Center Staff

Gustave Roussy

• Fabrice Barlesi, General Director of Gustave Roussy, medical oncologist
• David Planchard, thoracic oncologist, chairman of the thoracic cancer commitee of Gustave Roussy and president of the International Thoracic Cancer Center
• Benjamin Besse, medical oncologist, director of clinical research at Gustave Roussy

Lung cancer treatment

Patients with lung, pleural or mediastinal cancer may be offered different treatments, depending on the type of cancer and its spread or stage at the time of diagnosis. Treatments may be combined during therapy.

Local treatments

Surgery